We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Featured Articles

Digital interface with icons for policies, regulations and law highlighting data compliance concepts.

Data Compliance: Can AI Help Users Navigate New Technologies and Regulations?

AI tools are reshaping how labs handle compliance, from automating audit trails to improving data reuse and accuracy. In this article, we examine how the rise of AI is transforming compliance and how users can stay informed.

3D illustration of antibodies, central to immune responses in both cancer and allergy research.

The Surprising Connection Between Cancer and Allergy

IgE, best known for mediating allergic reactions, may also shape cancer outcomes. Learn how this immune molecule could serve as both a biomarker and a basis for next-generation therapies.

Colorful circular DNA sequence visualization representing data patterns in bioinformatics.

An Introduction to Bioinformatics, Bioinformatics Tools and Applications

This article introduces the field of bioinformatics and its importance as a cornerstone of biological research, as well as its history from the comparative analysis of the first amino acid sequences to the advent of high-throughput sequencing.

Latest Articles

Person holding a GLP-1 injection pen used for managing type 2 diabetes and weight loss.

Beyond GLP-1s: Rethinking Obesity Treatment for the Long Term

GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and improved metabolic health. However, concerns about long-term safety, cost, and accessibility remain.

Hand holding a weight loss drug injector above a bathroom scale with feet in socks.

The Promise and Perils of Weight Loss Drugs

This article examines the rise of GLP-1 weight loss drugs, highlighting their effectiveness in obesity and diabetes management while addressing concerns over side effects, mental health risks, high costs and long-term sustainability.

Futuristic capsule with digital data beside a stethoscope, symbolizing AI in precision medicine.

How Is AI Speeding Pharma’s Journey Toward Precision Medicine?

This article explores how AI is transforming precision medicine by streamlining drug discovery, improving patient stratification and treatment prediction, and accelerating clinical trials while highlighting challenges around data quality.

Glowing stick and ball molecules representing AI-driven generative chemistry.

Generative Chemistry: Navigating Vast Chemical Space in Drug Discovery

This article explores how generative chemistry accelerates drug design, identifies novel compounds and complements traditional computational tools.

A patient talking to a doctor as part of a clinical trial with the words Biomarkers in Focus displayed overhead.

How Digital Biomarkers Enable Patient-Centric Clinical Trials

Explore how digital biomarkers are transforming clinical trials with real-time data, continuous monitoring and AI-driven patient insights.

Person analyzing data dashboards with AI-driven data collaboration visuals.

How Collaboration Can Help Research Go Further

Explore how data collaboration and colocation are enabling breakthroughs in life sciences and reducing drug development time and costs.

The front of the White House in America in blue with the words European Pharma React to US Uncertainty overlaid.

European Pharma Experts React to US Tariff Uncertainty

Learn more about the effects US pharmaceutical tariffs could have on European companies and their strategies for overcoming cost and supply chain challenges.

A doctor talking to a cancer patient while they receive cancer therapy via an IV drip.

What’s Next for Cancer Precision Medicine?

Explore the future of precision medicine cancer therapy. Understand personalized treatment strategies and innovations shaping oncology care.

A blue open drug pill made from circuit boards, representing AI-driven drug discovery.

Investing in Biology: The Key to Sustainable Innovation in Drug Development and Healthcare

Dr. John Beeler, BPGbio, discusses why investing in biology is essential for AI-driven drug discovery and for building a more sustainable, cost-effective healthcare system worldwide.

A person holding a tube, representing optimal storage conditions to preserve sample integrity.

Forgotten Biological Samples Threaten Research Integrity

Dr. Jennifer Man, director of Science at UK Biocentre, explains why biological sample storage must evolve to prevent costly research losses and meet new regulations with automated, climate-friendly systems.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter